FDA inspection
Intas Pharmaceuticals Limited: FDA inspection ending Feb 28, 2020
FDA inspection 1119170 · Voluntary Action Indicated (VAI) · Sanand
Key facts
| Inspection ID | 1119170 |
|---|---|
| Firm | Intas Pharmaceuticals Limited |
| FEI number | 3004011473 |
| Address | Plot No. 5 To 14, Pharmez, Nr. Village Matoda, Sarkhej-Bavla National Highway No. 8-A |
| City | Sanand |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Feb 28, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data